SymBiosis Capital Partners
Latest statistics and disclosures from SymBiosis Capital Partners's latest quarterly 13F-HR filing:
- Central Index Key (CIK): 0002006045
Tip: Access up to 7 years of quarterly data
Positions held by SymBiosis Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for SymBiosis Capital Partners
SymBiosis Capital Partners holds 6 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Evommune Com Shs (EVMN) | 55.8 | $29M | 1.3M | 22.99 |
|
|
| Inventiva Ads (IVA) | 24.8 | $13M | 2.4M | 5.55 |
|
|
| Wave Life Sciences SHS (WVE) | 10.3 | $5.4M | 750k | 7.25 |
|
|
| Rani Therapeutics Holdings Com Cl A (RANI) | 5.1 | $2.7M | 3.7M | 0.73 |
|
|
| Clene Nanomedicine Com New (CLNN) | 4.0 | $2.1M | 431k | 4.93 |
|
|
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $2.4k | 150k | 0.02 |
|
Past Filings by SymBiosis Capital Partners
SEC 13F filings are viewable for SymBiosis Capital Partners going back to 2026
- SymBiosis Capital Partners 2026 Q1 filed May 12, 2026